Nyxoah Sa (BE:NYXH) has released an update.
Nyxoah SA, a medical technology firm specializing in treatments for Obstructive Sleep Apnea (OSA), has appointed Dr. Maurits S. Boon, an expert in sleep surgery, as their new Chief Medical Officer. Dr. Boon is recognized for his work with hypoglossal nerve stimulation therapy, indicating a strategic move for Nyxoah as they gear up to enter the U.S. market. The company’s flagship Genio system, a leadless and battery-free neurostimulation therapy for OSA, is central to Nyxoah’s mission to simplify sleep for patients.
For further insights into BE:NYXH stock, check out TipRanks’ Stock Analysis page.
